US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Jade Biosciences

16.94

-0.8000-4.51%

Post-market: 16.940.00000.00%16:25 EDT

Volume:2.60M

Turnover:44.54M

Market Cap:833.76M

PE:-8.02

High:18.23

Open:17.52

Low:16.51

Close:17.74

52wk High:28.00

52wk Low:6.57

Shares:49.22M

Float Shares:33.00M

Volume Ratio:1.47

T/O Rate:7.88%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1125

EPS(LYR):-3.1931

ROE:-89.18%

ROA:-33.59%

PB:0.29

PE(LYR):-5.31

Loading ...

Overview Company News Filings

Jade Biosciences Closes Public Offering of Shares

MT Newswires Live

Press Release: Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Jade Biosciences Launches Major Underwritten Equity Offering

Is Jade Biosciences (JBIO) Fairly Priced As Shares Swing And Losses Mount?

Simply Wall St.

JADE101 Phase 1 Trial Marks Key Early Milestone for Jade Biosciences Investors

BUZZ-U.S. STOCKS ON THE MOVE-UnitedHealth, Pinterest, Celcuity

Jade Biosciences 10M share Secondary priced at $15.00

Jade Biosciences prices 10 million-share follow-on at $15, raising $150 million gross

Jade Biosciences - Public Offering Priced at $15 per Share

THOMSON REUTERS

Press Release: Jade Biosciences Announces Pricing of Public Offering of Common Stock

BUZZ-Jade Biosciences falls on planned equity offering

Jade Biosciences Plans Public Offering

MT Newswires Live

Jade Biosciences announces common stock offering, no amount given

Jade Biosciences plans underwritten public offering of common stock, pre-funded warrants

Jade Biosciences - Net Proceeds to Fund Clinical Trials, Preclinical Studies, and Corporate Purposes

THOMSON REUTERS

Jade Biosciences Announces Proposed Underwritten Public Offering

THOMSON REUTERS

Wedbush Keeps Their Buy Rating on Jade Biosciences (JBIO)

Harrison Lifts JBIO Price Target to $74 on Promising JADE101 Data and Attractive IgA Nephropathy Opportunity

Jefferies says Jade Biosciences JADE101 data came in line with bull case

Wedbush Raises Price Target on Jade Biosciences to $45 From $34, Maintains Outperform Rating

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JBIO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","market":"US","secType":"STK","nameCN":"Jade Biosciences","latestPrice":16.94,"timestamp":1780689600000,"preClose":17.74,"halted":0,"volume":2600892,"hourTrading":{"tag":"盘后","latestPrice":16.94,"preClose":16.94,"latestTime":"16:25 EDT","volume":170616,"amount":2890094.217,"timestamp":1780691159548,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04509582863585103,"floatShares":33002000,"shares":49218491,"eps":-2.112544,"marketStatus":"Closed","change":-0.8,"latestTime":"06-05 16:00:00 EDT","open":17.52,"high":18.23,"low":16.51,"amount":44544542,"amplitude":0.096956,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.112544,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":5,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":17.74,"preHourTrading":{"tag":"盘前","latestPrice":17.52,"preClose":17.74,"latestTime":"09:29 EDT","volume":295,"amount":5248.64944,"timestamp":1780666199999,"change":-0.22,"changeRate":-0.012401,"amplitude":0.050169},"postHourTrading":{"tag":"盘后","latestPrice":16.94,"preClose":16.94,"latestTime":"16:25 EDT","volume":170616,"amount":2890094.217,"timestamp":1780691159548,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.465139,"impliedVol":0.3113,"impliedVolPercentile":0.1195},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","floatShares":33002000,"roa":"-33.59%","roe":"-89.18%","lyrEps":-3.193116,"volumeRatio":1.465139,"shares":49218491,"dividePrice":0,"high":18.23,"amplitude":0.096956,"preClose":17.74,"low":16.51,"week52Low":6.565,"pbRate":"0.29","week52High":28,"institutionHeld":0,"latestPrice":16.94,"eps":-2.112544,"divideRate":0,"volume":2600892,"delay":0,"ttmEps":-2.112544,"open":17.52,"prevYearClose":15.43,"prevWeekClose":21.04,"prevMonthClose":21.04,"prevQuarterClose":14.05,"fiveDayClose":21.04,"twentyDayClose":24.22,"sixtyDayClose":14.02,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.15429122468659595},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-07","symbol":"JBIO","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2026-03-06","symbol":"JBIO","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772773200000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2025-11-13","symbol":"JBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.57,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2025-08-13","symbol":"JBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.86},{"date":"2025-04-29","symbol":"JBIO","amount":2.4,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-25","defaultRemindTime":1745933400000,"name":"Jade Biosciences","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-28","payableDate":"2025-04-25","currency":"USD","dateTimestamp":1745899200000,"payDate":"2025-04-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JBIO\",market:\"US\",,,undefined,":[{"executeDate":"2025-04-29","recordDate":"2025-04-25","paymentDate":"2025-04-28","value":2.4,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":10,"updateTime":1773288000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JBIO","date":"2026-06-04","current":-7.952497,"percent":0.337079,"low":-10.392766,"twenty":-7.487348,"median":-5.210913,"eighty":-2.696034,"high":-2.319279,"avg":-5.142513,"sd":2.392591,"marketCap":868240201},"quantilePoints":[{"date":"2025-05-16","current":-2.4743,"twenty":-2.881556,"median":-2.868851,"eighty":-2.514424,"marketCap":232480279},{"date":"2025-05-23","current":-2.511409,"twenty":-2.870857,"median":-2.517932,"eighty":-2.47965,"marketCap":235966978},{"date":"2025-05-30","current":-2.432499,"twenty":-2.695315,"median":-2.507901,"eighty":-2.466944,"marketCap":228552715},{"date":"2025-06-06","current":-2.363881,"twenty":-2.548988,"median":-2.487393,"eighty":-2.464507,"marketCap":222105530},{"date":"2025-06-13","current":-2.381035,"twenty":-2.548988,"median":-2.48419,"eighty":-2.428382,"marketCap":223717326},{"date":"2025-06-20","current":-3.228464,"twenty":-2.618978,"median":-2.48419,"eighty":-2.41603,"marketCap":303340063},{"date":"2025-06-27","current":-3.17357,"twenty":-2.886906,"median":-2.487393,"eighty":-2.426323,"marketCap":298182315},{"date":"2025-07-03","current":-3.822008,"twenty":-3.217485,"median":-2.511409,"eighty":-2.437181,"marketCap":359108215},{"date":"2025-07-11","current":-3.609293,"twenty":-3.553713,"median":-2.554094,"eighty":-2.45809,"marketCap":339121941},{"date":"2025-07-18","current":-3.262773,"twenty":-3.420594,"median":-2.844205,"eighty":-2.467494,"marketCap":306563656},{"date":"2025-07-25","current":-2.857929,"twenty":-3.391775,"median":-2.873866,"eighty":-2.470924,"marketCap":268525263},{"date":"2025-08-01","current":-2.466808,"twenty":-3.382854,"median":-2.844205,"eighty":-2.467494,"marketCap":231776307},{"date":"2025-08-08","current":-2.511409,"twenty":-3.347859,"median":-2.705254,"eighty":-2.467494,"marketCap":235966978},{"date":"2025-08-15","current":-2.350869,"twenty":-3.260028,"median":-2.645214,"eighty":-2.467494,"marketCap":220882962},{"date":"2025-08-22","current":-2.56269,"twenty":-3.244933,"median":-2.581542,"eighty":-2.467494,"marketCap":240785267},{"date":"2025-08-29","current":-2.805764,"twenty":-3.217485,"median":-2.645214,"eighty":-2.470924,"marketCap":263623978},{"date":"2025-09-05","current":-2.70159,"twenty":-3.17357,"median":-2.64603,"eighty":-2.473669,"marketCap":253835959},{"date":"2025-09-12","current":-2.694645,"twenty":-3.152985,"median":-2.64603,"eighty":-2.4743,"marketCap":253183424},{"date":"2025-09-19","current":-2.677282,"twenty":-3.087798,"median":-2.64603,"eighty":-2.473669,"marketCap":251552088},{"date":"2025-09-26","current":-2.798819,"twenty":-3.080936,"median":-2.64603,"eighty":-2.4743,"marketCap":262971443},{"date":"2025-10-03","current":-2.892576,"twenty":-3.080936,"median":-2.67381,"eighty":-2.479351,"marketCap":271780660},{"date":"2025-10-10","current":-3.264131,"twenty":-3.152985,"median":-2.690514,"eighty":-2.480987,"marketCap":306691262},{"date":"2025-10-17","current":-3.397822,"twenty":-3.16343,"median":-2.70159,"eighty":-2.487393,"marketCap":319252553},{"date":"2025-10-24","current":-3.448173,"twenty":-3.228464,"median":-2.743259,"eighty":-2.487393,"marketCap":323983428},{"date":"2025-10-31","current":-3.420393,"twenty":-3.264131,"median":-2.760622,"eighty":-2.487393,"marketCap":321373290},{"date":"2025-11-07","current":-3.10787,"twenty":-3.295384,"median":-2.802291,"eighty":-2.501116,"marketCap":292009233},{"date":"2025-11-14","current":-3.361361,"twenty":-3.350943,"median":-2.840774,"eighty":-2.504393,"marketCap":315826746},{"date":"2025-11-21","current":-5.620897,"twenty":-3.393147,"median":-2.85789,"eighty":-2.511409,"marketCap":528128273},{"date":"2025-11-28","current":-6.276995,"twenty":-3.403031,"median":-2.873866,"eighty":-2.511409,"marketCap":589773908},{"date":"2025-12-05","current":-6.071353,"twenty":-3.439839,"median":-2.892576,"eighty":-2.514154,"marketCap":570452142},{"date":"2025-12-12","current":-7.266038,"twenty":-3.474564,"median":-2.963052,"eighty":-2.522532,"marketCap":682702402},{"date":"2025-12-19","current":-8.108193,"twenty":-3.595569,"median":-2.993278,"eighty":-2.527742,"marketCap":761829634},{"date":"2025-12-26","current":-8.093505,"twenty":-3.607234,"median":-3.022611,"eighty":-2.532681,"marketCap":760449508},{"date":"2026-01-02","current":-7.554917,"twenty":-3.822008,"median":-3.080936,"eighty":-2.536797,"marketCap":709844883},{"date":"2026-01-09","current":-6.487534,"twenty":-5.801079,"median":-3.116551,"eighty":-2.545612,"marketCap":609555716},{"date":"2026-01-16","current":-7.197491,"twenty":-6.02239,"median":-3.152985,"eighty":-2.555745,"marketCap":676261813},{"date":"2026-01-23","current":-8.333421,"twenty":-6.159485,"median":-3.153012,"eighty":-2.557134,"marketCap":782991569},{"date":"2026-01-30","current":-7.530436,"twenty":-6.394505,"median":-3.1685,"eighty":-2.564099,"marketCap":707544672},{"date":"2026-02-06","current":-7.045707,"twenty":-6.577625,"median":-3.177319,"eighty":-2.571103,"marketCap":662000509},{"date":"2026-02-13","current":-7.251349,"twenty":-6.621691,"median":-3.225463,"eighty":-2.577189,"marketCap":681322276},{"date":"2026-02-20","current":-7.124047,"twenty":-6.808238,"median":-3.251382,"eighty":-2.579625,"marketCap":669361182},{"date":"2026-02-27","current":-7.128943,"twenty":-6.986952,"median":-3.264131,"eighty":-2.583458,"marketCap":669821224},{"date":"2026-03-06","current":-6.795998,"twenty":-6.986952,"median":-3.314482,"eighty":-2.597415,"marketCap":638538365},{"date":"2026-03-13","current":-5.364757,"twenty":-6.933093,"median":-3.361361,"eighty":-2.602624,"marketCap":683523737},{"date":"2026-03-20","current":-5.449912,"twenty":-6.913508,"median":-3.389716,"eighty":-2.60436,"marketCap":694373320},{"date":"2026-03-27","current":-5.399593,"twenty":-6.874338,"median":-3.399558,"eighty":-2.630404,"marketCap":687962203},{"date":"2026-04-02","current":-6.200823,"twenty":-6.843002,"median":-3.403031,"eighty":-2.640126,"marketCap":790046917},{"date":"2026-04-10","current":-7.056243,"twenty":-6.843002,"median":-3.432606,"eighty":-2.644683,"marketCap":899035912},{"date":"2026-04-17","current":-8.46904,"twenty":-6.943865,"median":-3.47248,"eighty":-2.645867,"marketCap":1079040359},{"date":"2026-04-24","current":-9.757975,"twenty":-7.080959,"median":-3.477689,"eighty":-2.64603,"marketCap":1243263595},{"date":"2026-05-01","current":-9.451524,"twenty":-7.125026,"median":-3.585277,"eighty":-2.656356,"marketCap":1204218641},{"date":"2026-05-08","current":-9.381799,"twenty":-7.197491,"median":-3.600715,"eighty":-2.670835,"marketCap":1195335061},{"date":"2026-05-15","current":-9.189592,"twenty":-7.279748,"median":-3.609293,"eighty":-2.676588,"marketCap":1191053783},{"date":"2026-05-22","current":-8.934431,"twenty":-7.436993,"median":-3.822008,"eighty":-2.684564,"marketCap":1157982667},{"date":"2026-05-29","current":-7.936639,"twenty":-7.480494,"median":-5.132517,"eighty":-2.691341,"marketCap":1028659795},{"date":"2026-06-04","current":-6.698919,"twenty":-7.487348,"median":-5.210913,"eighty":-2.696034,"marketCap":868240201}],"updateTime":1780688060820},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JBIO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641147791","title":"Jade Biosciences Closes Public Offering of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2641147791","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641147791?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:18","pubTimestamp":1780690690,"startTime":"0","endTime":"0","summary":"Jade Biosciences  said late Friday it has closed its public offering of 11.5 million shares, including the full exercise of an over-allotment option, raising $172.5 million for the clinical-stage biotechnology company.The company said net proceeds will be used among others for clinical trials, preclinical studies, working capital and other general corporate purposes.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641414717","title":"Press Release: Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2641414717","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641414717?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:01","pubTimestamp":1780689660,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO and VANCOUVER, British Columbia, June 05, 2026  -- Jade Biosciences, Inc.  , a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced that it has closed its previously announced public offering of 11,500,000 shares of its common stock, including 1,500,000 shares sold pursuant to the underwriters' full exercise of their option to purchase additional shares. The shares of common stock were sold to the public at a price of $15.00 per share. The gross proceeds to Jade from the offering, before deducting the underwriting discounts and commissions and other offering expenses, were $172.5 million. All of the shares of common stock sold in the public offering were sold by Jade.This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","JBIO","USA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641986921","title":"Jade Biosciences Launches Major Underwritten Equity Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2641986921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641986921?lang=en_us&edition=fundamental","pubTime":"2026-06-05 06:58","pubTimestamp":1780613931,"startTime":"0","endTime":"0","summary":"Jade Biosciences ( ($JBIO) ) just unveiled an update. On June 3, 2026, Jade Biosciences, Inc. entered into an underwriting agreement with a syndica...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jade-biosciences-launches-major-underwritten-equity-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jade-biosciences-launches-major-underwritten-equity-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQR","BK4539","BK4139","BK4585","JBIO","BK4588","BK4215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641160690","title":"Is Jade Biosciences (JBIO) Fairly Priced As Shares Swing And Losses Mount?","url":"https://stock-news.laohu8.com/highlight/detail?id=2641160690","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641160690?lang=en_us&edition=fundamental","pubTime":"2026-06-05 05:38","pubTimestamp":1780609120,"startTime":"0","endTime":"0","summary":"Jade Biosciences stock reaction\n\nJade Biosciences (JBIO) has attracted fresh attention after recent share price swings, including a move higher in the latest session while remaining down over the past week and month but up over the past 3 months.\n\nSee our latest analysis for Jade Biosciences.\n\nAt the current share price of $17.74, Jade Biosciences has a 1 day share price return of 0.85%, a 30 day share price return down 29.77%, and a 1 year total shareholder return of 157.47%, indicating...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jbio/jade-biosciences/news/is-jade-biosciences-jbio-fairly-priced-as-shares-swing-and-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jbio/jade-biosciences/news/is-jade-biosciences-jbio-fairly-priced-as-shares-swing-and-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641696851","title":"JADE101 Phase 1 Trial Marks Key Early Milestone for Jade Biosciences Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2641696851","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641696851?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:33","pubTimestamp":1780590793,"startTime":"0","endTime":"0","summary":"Jade Biosciences, Inc. ($JBIO) announced an update on their ongoing clinical study. Jade Biosciences, Inc. has launched a Phase 1 trial called “A S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jade101-phase-1-trial-marks-key-early-milestone-for-jade-biosciences-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jade101-phase-1-trial-marks-key-early-milestone-for-jade-biosciences-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JBIO","ISBC","BK4539","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640616695","title":"BUZZ-U.S. STOCKS ON THE MOVE-UnitedHealth,  Pinterest, Celcuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2640616695","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640616695?lang=en_us&edition=fundamental","pubTime":"2026-06-04 23:47","pubTimestamp":1780588020,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-UnitedHealth, Pinterest, Celcuity Workspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nL6N42C0WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DAMD","AMD","AMDU","BTSG","ICOI","AVEX","RTX","AVL","AEVA","AVGX","CELC","CONY","PINS","RTXG","COIW","MARO","CONL","SNBR","FIVE","AVGO","DDD","ZTS","UNH","CRWD","COIO","MARA","INTC","GUTS","CRWL","HON","RIOT","FIAT","COIN","LFTO","CSGP","LINT","COIA","COIG","RTYY","STLD","AVY","CONI","BIIB","COII","NUE","SSMR","JBIO","CONX","SNDX","HUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640615156","title":"Jade Biosciences 10M share Secondary priced at $15.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2640615156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640615156?lang=en_us&edition=fundamental","pubTime":"2026-06-04 18:37","pubTimestamp":1780569453,"startTime":"0","endTime":"0","summary":"Jefferies, TD Cowen and UBS acted as joint book running managers for the offering. Published first on TheFly – the ultimate source for real-time, m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-10m-share-secondary-priced-at-15-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-10m-share-secondary-priced-at-15-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO","LU1829250122.USD","BK4534","BK4539","BK4585","BK4118","IE0034235071.USD","LU1863844749.USD","UBS","BK4139","LU1863844665.USD","LU3187612489.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640113644","title":"Jade Biosciences prices 10 million-share follow-on at $15, raising $150 million gross","url":"https://stock-news.laohu8.com/highlight/detail?id=2640113644","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640113644?lang=en_us&edition=fundamental","pubTime":"2026-06-04 10:58","pubTimestamp":1780541898,"startTime":"0","endTime":"0","summary":"Jade Biosciences priced a follow-on offering of 10,000,000 common shares at USD 15 per share.Gross proceeds expected at USD 150 million, excluding any exercise of the 1,500,000-share over-allotment option.Closing expected June 5, 2026, subject to customary conditions.Net proceeds earmarked for clinical trials, preclinical work, manufacturing support, R&D, capital spending, working capital, general corporate purposes.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL8tW4xN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014013.SGD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","NDAQ","IE00BN0W2T93.GBP","BK4139","IE00BGHQF748.EUR","BK4588","BK4112","BK4539","SG9999014005.SGD","JBIO","LU0314104364.USD","BK4585","LU2210150020.SGD","IE00BN0W2W23.USD","SG9999014039.USD","IE00BKPKM429.USD","SG9999014021.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640364451","title":"Jade Biosciences - Public Offering Priced at $15 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2640364451","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640364451?lang=en_us&edition=fundamental","pubTime":"2026-06-04 10:58","pubTimestamp":1780541884,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA61174S:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640362381","title":"Press Release: Jade Biosciences Announces Pricing of Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2640362381","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640362381?lang=en_us&edition=fundamental","pubTime":"2026-06-04 10:58","pubTimestamp":1780541880,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO and VANCOUVER, British Columbia, June 03, 2026  -- Jade Biosciences, Inc.  , a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the pricing of a public offering of 10,000,000 shares of its common stock. The shares of common stock are being sold to the public at a price of $15.00 per share. The gross proceeds to Jade from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be $150.0 million, excluding any exercise of the underwriters' option to purchase additional shares. The offering is expected to close on June 5, 2026, subject to the satisfaction of customary closing conditions. In addition, Jade has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock to be sold in the p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","USA","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640041184","title":"BUZZ-Jade Biosciences falls on planned equity offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640041184","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640041184?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:10","pubTimestamp":1780521015,"startTime":"0","endTime":"0","summary":"BUZZ-Jade Biosciences falls on planned equity offering** Jade Biosciences' JBIO.O shares down 6.2% after hours to $16.50 as it looks to raise equity** Autoimmune diseases-focused biotech announces offering comprised of stock and pre-funded warrants; deal size not disclosed** Jefferies, TD Cowen and UBS joint bookrunners** Co intends to use net offering proceeds to fund clinical trials, preclinical studies, R&D, and for capex, among other purposes** With ~49.4 mln shares outstanding, co has about $870 mln market cap** JBIO stock ended Weds down 0.9% at $17.59, up 14% YTD** 6 analysts rate the stock \"strong buy\", the other 4 \"buy\"; median PT of $43.50 up from $24.50 a month ago, according to LSEG data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nL6N42B1A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","JEF","BK4139","BK4539","BK4127","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640618497","title":"Jade Biosciences Plans Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640618497","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640618497?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:51","pubTimestamp":1780519906,"startTime":"0","endTime":"0","summary":"Jade Biosciences  said late Wednesday it plans to offer shares, or pre-funded warrants to purchase shares, in an underwritten public offering.Jade said it intends to grant its underwriters a 30-day option to buy up to an additional 15% of the securities offered.Net proceeds will be used among others for clinical trials, pre-clinical studies, and working capital, the clinical-stage firm said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640103181","title":"Jade Biosciences announces common stock offering, no amount given","url":"https://stock-news.laohu8.com/highlight/detail?id=2640103181","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640103181?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:05","pubTimestamp":1780517147,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock or, in lieu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-announces-common-stock-offering-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-announces-common-stock-offering-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640189743","title":"Jade Biosciences plans underwritten public offering of common stock, pre-funded warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2640189743","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640189743?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:01","pubTimestamp":1780516901,"startTime":"0","endTime":"0","summary":"Jade Biosciences launched a proposed underwritten public offering of common stock or pre-funded warrants in lieu of common stock.Underwriters get a 30-day option to buy up to 15% more securities at the offering price, less discounts and commissions.Proceeds earmarked for clinical trials, preclinical studies, manufacturing support, research and development, capital spending, working capital.Jefferies, TD Cowen, UBS Investment Bank named joint book-runners; LifeSci Capital also a book-runner; BTIG lead manager.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL9nYVYd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","SG9999014039.USD","IE00B64PRP62.GBP","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4588","BK4139","IE00BN0W2W23.USD","SG9999014013.SGD","NDAQ","LU0314104364.USD","IE00BKPKM429.USD","BK4539","LU2210150020.SGD","IE00BN0W2T93.GBP","LU2210149790.SGD","LU2095319765.USD","IE00BGHQF748.EUR","BK4585","IE00BN0W2V16.EUR","BK4112","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640189765","title":"Jade Biosciences - Net Proceeds to Fund Clinical Trials, Preclinical Studies, and Corporate Purposes","url":"https://stock-news.laohu8.com/highlight/detail?id=2640189765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640189765?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:01","pubTimestamp":1780516860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1RTQKS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640189762","title":"Jade Biosciences Announces Proposed Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640189762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640189762?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:01","pubTimestamp":1780516860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1RTQKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640943300","title":"Wedbush Keeps Their Buy Rating on Jade Biosciences (JBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640943300","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640943300?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:38","pubTimestamp":1780403916,"startTime":"0","endTime":"0","summary":"Wedbush analyst Laura Chico maintained a Buy rating on Jade Biosciences today and set a price target of $45.00. According to TipRanks, Chico is a 5...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917107","title":"Harrison Lifts JBIO Price Target to $74 on Promising JADE101 Data and Attractive IgA Nephropathy Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917107","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917107?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:16","pubTimestamp":1780398977,"startTime":"0","endTime":"0","summary":"BTIG analyst Julian Harrison has maintained their bullish stance on JBIO stock, giving a Buy rating yesterday. Julian Harrison has given his Buy ra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/harrison-lifts-jbio-price-target-to-74-on-promising-jade101-data-and-attractive-iga-nephropathy-opportunity-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/harrison-lifts-jbio-price-target-to-74-on-promising-jade101-data-and-attractive-iga-nephropathy-opportunity-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640961256","title":"Jefferies says Jade Biosciences JADE101 data came in line with bull case","url":"https://stock-news.laohu8.com/highlight/detail?id=2640961256","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640961256?lang=en_us&edition=fundamental","pubTime":"2026-06-02 03:40","pubTimestamp":1780342808,"startTime":"0","endTime":"0","summary":"Jefferies noted that Jade Biosciences (JBIO)’ interim JADE101 trial data hit the firm’s bull case expectations. The firm added that management sees...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jefferies-says-jade-biosciences-jade101-data-came-in-line-with-bull-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jefferies-says-jade-biosciences-jade101-data-came-in-line-with-bull-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640680719","title":"Wedbush Raises Price Target on Jade Biosciences to $45 From $34, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2640680719","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640680719?lang=en_us&edition=fundamental","pubTime":"2026-06-01 23:34","pubTimestamp":1780328080,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) has an average rating of buy and mean price target of $38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":98,"code":"91000000","status":"200"}]}}